Resources Contact Us Home
Immunological composition of measles virus utilizing recombinant poxvirus

Image Number 12 for United States Patent #5759841.

What is described is a recombinant poxvirus, such as vaccinia virus or canarypox virus, containing foreign DNA from Morbillivirus. In one embodiment, the foreign DNA is expressed in a host by the production of a measles virus glycoprotein. In another embodiment, the foreign DNA is expressed in a host by the production of at least two measles virus glycoproteins. What is also described is a vaccine containing the recombinant poxvirus for inducing an immunological response in a host animal inoculated with the vaccine. By the present invention, cross-protection of dogs against canine distemper is obtained by inoculating the dog with the recombinant poxvirus.

  Recently Added Patents
Organic elelectroluminescent display
LED lighting module
Connector with shielding device and method for manufacturing connector
Lamination sheet
Rear body panel cover for a motor vehicle
Domestic soda-water preparing device
  Randomly Featured Patents
Split data path fast at-bus on chip circuits systems and methods
Device for protecting medical devices during a coating process
Lead-free low softening point glass
Hermetically sealed electrical terminal
Logic arrangement, data structure, system and method for multilinear representation of multimodal data ensembles for synthesis recognition and compression
Automated retractable step apparatus
Downhole recovery system
Tunable bidirectional multiplexer/demultiplexer for optical transmission system
Power tool with a rotating and/or hammering drive mechanism
Process of removing holefill residue from a metallic surface of an electronic substrate